StemSight
PrivateLast Round
Seed
Feb 11, 2025
Total Funding Raised
$1.89M
Company Overview
StemSight operates in Healthcare & Life Sciences and is based in Tampere. Its latest recorded funding round was a Seed round in February 2025.
StemSight is a biotechnology company developing off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs) to treat corneal blindness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, 3D Printing, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemSight Comparables
Compare StemSight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellusion Inc. | 77% | |
| Alcon | 74% | |
| Chiesi Farmaceutici S.p.A. | 73% |
For institutional investors. Book with your work email.
StemSight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 11, 2025 | ||||
| Pre Seed | Aug 31, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
StemSight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Seed |
| Biothom Oy | Seed |
| European Regional Development Fund (ERDF) | Grant |
| Voima Ventures | Pre Seed, Seed |
| Avohoidon Tutkimussäätiö | Pre Seed |
| Stephen Industries Inc Oy | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 891% MoM.
- Jan 6, 2026
Monthly visitors grew 258% MoM, reaching 974.
For institutional investors. Book with your work email.
StemSight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StemSight's valuation, stock price, and market status.
Is StemSight a public or private company?
StemSight is a private company.
What is the current stock price of StemSight?
StemSight is a private company, so its shares have no public market price. Caplight tracks StemSight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StemSight worth (valuation)?
Valuation information for StemSight is not publicly available.
Can I buy StemSight stock?
StemSight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StemSight's last funding round?
StemSight's most recent funding round was Seed on February 11, 2025.
Who are the main investors in StemSight?
Key investors in StemSight include Voima Ventures.
Will StemSight IPO soon?
No public IPO plans have been announced for StemSight.
How can I track StemSight secondary market activity?
Caplight tracks bids, offers, and trades in StemSight's shares on secondary markets.